Product
Vaccine Group A: DNA-HIV-PT123 and AIDSVAX B/E
1 clinical trial
1 indication
Indication
HIV InfectionsClinical trial
A Phase IIb Three-arm, Two-stage HIV Prophylactic Vaccine Trial With a Second Randomisation to Compare TAF/FTC to TDF/FTC as Pre-exposure ProphylaxisStatus: , Estimated PCD: 2024-12-31